(Q58053733)

English

Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis

scientific article published on 01 January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

X Garcia-del-Muro

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C Vadell

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G Pérez Manga

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

I Bover

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J Rifá

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Beltrán

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M M Barros

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J R Germá

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

X Fabregat

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A Salvador

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P Viladiu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

193-195

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900367-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(97)00367-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9624257%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58053733&oldid=1759027439"